Literature DB >> 8858968

In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.

R B Kim1, H Yamazaki, K Chiba, D O'Shea, M Mimura, F P Guengerich, T Ishizaki, T Shimada, G R Wilkinson.   

Abstract

Chlorzoxazone's disposition after oral administration was determined in 20 young healthy Caucasian men and a similar group of Japanese men. The drug's plasma concentrations were significantly higher and its rate of elimination slower in Japanese compared to Caucasian men. Accordingly, chlorzoxazone's oral clearance was smaller (40%) in Japanese men and a similar difference (30%) was still apparent after normalizing for body weight (3.74 +/- 1.23 versus 5.05 +/- 1.41 ml.min-1.kg-1, P < .05). This slower elimination was associated with a reduced (fractional) clearance by 6-hydroxylation (2.34 +/- 1.04 ml.min-1.kg-1 versus 3.23 +/- 1.10, P < .05). Because such metabolism is mediated by cytochrome P4502E1 (CYP2E1), these findings suggest a lower level of the enzyme's catalytic activity in Japanese men. This was confirmed by in vitro studies with microsomes prepared from livers of individuals representative of the two racial groups. CYP2E1 levels were lower (61% P < .002) and CYP2E1-mediated chlorzoxazone 6-hydroxylase (22%, P < .001) and aniline 4-hydroylase (35%, P < .0001) activities were reduced in Japanese preparations compared to those from Caucasians. No relationships were found between measures of CYP2E1 activity, both in vivo and in vitro, and genomic polymorphisms in the CYP2E1 gene identified by Rsal/Pstl and Dral restriction fragment length polymorphisms. Collectively, these data show an interracial difference in CYP2E1 activity. Because this enzyme is importantly involved in the activation of environmental procarcinogens, such a difference may account, in part, for the lower rate of some cancers, e.g., lung cancer, in Japanese compared to Caucasians men.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858968

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.

Authors:  Hermann M Bolt; Peter H Roos; Ricarda Thier
Journal:  Int Arch Occup Environ Health       Date:  2003-03-01       Impact factor: 3.015

2.  Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.

Authors:  Dong Lu; Xiaodan Yu; Yukai Du
Journal:  Mol Biol Rep       Date:  2010-11-13       Impact factor: 2.316

3.  Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.

Authors:  Junling Yang; Minxia M He; Wei Niu; Steven A Wrighton; Li Li; Yang Liu; Chuan Li
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

4.  CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis.

Authors:  Keqing Yao; Haiping Qin; Lili Gong; Ran Zhang; Lianqing Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-04       Impact factor: 2.503

5.  CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Authors:  Gulzar Ahmad Bhat; Idrees Ayoub Shah; Muzamil Ashraf Makhdoomi; Beenish Iqbal; Rumaisa Rafiq; Sumaiya Nabi; Akbar Masood; Mohd Maqbool Lone; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2014-02-08

6.  Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.

Authors:  G J Burckart; R F Frye; P Kelly; R A Branch; A Jain; J J Fung; T E Starzl; R Venkataramanan
Journal:  Clin Pharmacol Ther       Date:  1998-03       Impact factor: 6.875

7.  Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene.

Authors:  M-Y Lee; N Mukherjee; A J Pakstis; S Khaliq; A Mohyuddin; S Q Mehdi; W C Speed; J R Kidd; K K Kidd
Journal:  Pharmacogenomics J       Date:  2008-07-29       Impact factor: 3.550

8.  Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis.

Authors:  Ming Yin; Zhibin Hu; Dongfeng Tan; Jaffer A Ajani; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

9.  An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.

Authors:  T Iwasa; H Sano; A Sugiura; N Uchiyama; K Hara; H Okochi; K Nakagawa; T Yasumori; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

10.  CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.

Authors:  Chang-Ming Gao; Toshiro Takezaki; Jian-Zhong Wu; Min-Bin Chen; Yan-Ting Liu; Jian-Hua Ding; Haruhiko Sugimura; Jia Cao; Nobuyuki Hamajima; Kazuo Tajima
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.